We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Risk of Heart Attack Doubles After Transient Ischemic Attack

By HospiMedica International staff writers
Posted on 05 Apr 2011
The risks for myocardial infarction (MI) among patients who have suffered a transient ischemic attack (TIA) is approximately double that of the general population, according to a new study.

Researchers at the Mayo Clinic (Rochester, MN, USA) used data from the Rochester Epidemiology Project to identify a cohort of residents who had had a TIA between 1985 and 1994, and then cross-referenced these with residents who had an MI between 1979 and 2006 to find all those who had had an MI after a TIA; follow-up ranged from 10 to as long as 20 years.

The researchers found that the average annual incidence of MI after TIA was 0.95%, which is twice the relative risk seen in the general population without TIA, and persisted over the long term. More...
In addition, the researchers found that the risk was particularly high for those under 60 years of age (who faced a 15-fold risk), and that mortality associated with an MI after TIA was 3 times that of patients who did not have an MI. Increasing age, male sex, and the use of lipid-lowering therapy at the time of the initial TIA were all independent risk factors for MI after TIA. The study was published in the April 2011 issue of Stroke.

"Now that we've shown that the ultimate endpoint of coronary artery disease, MI, is clearly heightened over the long-term in patients with TIA, we need to step back and consider how we can prevent that outcome,” said corresponding author professor Robert Brown, Jr., MD, MPH, chair of the department of neurology. "And we will need to consider how to select which patients with TIA should have a screening study.”

Previous studies have shown that coronary artery disease is the leading cause of death in the first 5 to 10 years after TIA; it accounts for 24%-64% of deaths, compared with 12%-28% of deaths attributed to stroke.

Related Links:
Mayo Clinic



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.